Huda Suliman explains the nuances of drug discovery in ageing research
Lifespan.io (LEAF) - 23-Oct-2019Indications are less clear with anti-ageing compounds than with disease specific drugs
Join the club for FREE to access the whole archive and other member benefits.
Ichor Therapeutics' contract research arm focused on aging
Icaria Life Sciences is the first biopharmaceutical contract research organization dedicated exclusively to the diseases of aging.
We bring industrial rigor and quality assurance to discovery workflows in new and emerging focus areas for aging. Our emphasis on process standardization and method robustness ensures experimental reproducibility.
Visit website: https://icarialifesciences.com/
See also: Ichor Therapeutics - Company that develops clinical products in the field of regenerative medicine
Details last updated 15-Nov-2019
Indications are less clear with anti-ageing compounds than with disease specific drugs